Sanofi ADR [SNY] stock prices are up 6.65% to $48.94 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SNY shares have gain 1.79% over the last week, with a monthly amount glided 2.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sanofi ADR [NASDAQ: SNY] stock has seen the most recent analyst activity on July 26, 2024, when Argus reiterated its Buy rating and also boosted its price target to $60 from $55. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on January 23, 2024, and set its price target to $55. JP Morgan downgraded its rating to a Neutral. Stifel downgraded its rating to a Hold. Berenberg upgraded its rating to Buy for this stock on September 06, 2023. In a note dated July 14, 2023, HSBC Securities initiated an Buy rating.
The stock price of Sanofi ADR [SNY] has been fluctuating between $45.22 and $58.97 over the past year. Currently, Wall Street analysts expect the stock to reach $62 within the next 12 months. Sanofi ADR [NASDAQ: SNY] shares were valued at $48.94 at the most recent close of the market. An investor can expect a potential return of 26.69% based on the average SNY price forecast.
Analyzing the SNY fundamentals
The Sanofi ADR [NASDAQ:SNY] reported sales of 47.68B for trailing twelve months, representing a drop of -13.36%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.81 points at the first support level, and at 46.68 for the second support level. However, for the 1st resistance point, the stock is sitting at 49.90, and for the 2nd resistance point, it is at 50.86.
Ratios To Look Out For
It’s worth pointing out that Sanofi ADR [NASDAQ:SNY]’s Current Ratio is 1.00. As well, the Quick Ratio is 0.65, while the Cash Ratio is 0.23. Considering the valuation of this stock, the price to sales ratio is 2.57, the price to book ratio is 1.57 and price to earnings (TTM) ratio is 26.98.
